Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
02/10/2005 | CA2534038A1 Inhibitors of akt activity |
02/10/2005 | CA2533901A1 Piperazine derivatives and their use as therapeutic agents |
02/10/2005 | CA2533363A1 3-amino choman and 2-amino tetralin derivatives |
02/10/2005 | CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
02/10/2005 | CA2527861A1 Alkynyl aryl carboxamides |
02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
02/09/2005 | EP1505061A1 Compound exhibiting pgd 2 receptor antagonism |
02/09/2005 | EP1504306A1 Photopolymerizable compositions comprising thianthrenium salts as cationic photoinitiators |
02/09/2005 | EP1503992A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
02/09/2005 | EP1503991A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof |
02/09/2005 | EP1503988A2 Fredericamycin derivatives |
02/09/2005 | EP1503986A2 Compositions and methods for treating heart failure |
02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
02/09/2005 | EP1503754A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
02/09/2005 | EP1421080B1 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides |
02/09/2005 | EP1204322B1 Fungicides |
02/09/2005 | EP1200076A4 Calcilytic compounds |
02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
02/09/2005 | CN1578779A Small organic molecule regulators of cell proliferation |
02/09/2005 | CN1578776A Heterocyclic retinoid compounds |
02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
02/09/2005 | CN1578662A Pyridine derivatives as nmda-receptor subtype blockers |
02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
02/09/2005 | CN1578625A Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones |
02/09/2005 | CN1188407C Imidazole derivatives with farnesyl transferase to inhibite activity and preparing method thereof |
02/08/2005 | US6852752 Urea compounds, compositions and methods of use and preparation |
02/08/2005 | US6852725 Imidazolyl derivatives |
02/08/2005 | US6852711 HIV protease inhibitors |
02/08/2005 | US6852673 Herbicidal pyridine compounds |
02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
02/03/2005 | WO2005009996A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
02/03/2005 | WO2005009995A1 Nicotinamide derivatives useful as pde4 inhibitors |
02/03/2005 | WO2005009994A1 Nicotinamide derivatives useful as pde4 inhibitors |
02/03/2005 | WO2005009969A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
02/03/2005 | WO2005009967A2 Quinolinone derivatives as inhibitors of c-fms kinase |
02/03/2005 | WO2005009959A1 Piperidine derivatives as ccr5 receptor modulators |
02/03/2005 | WO2005009958A1 Ppar active compounds |
02/03/2005 | WO2005009957A1 Tyrosine kinase inhibitors |
02/03/2005 | WO2005009373A2 Tyrosine kinase inhibitors |
02/03/2005 | WO2004106307A3 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
02/03/2005 | WO2004100998A3 Compositions and methods for non-invasive imaging of soluble beta-amyloid |
02/03/2005 | WO2004075840A3 Selective non-steroidal glucocorticoid receptor modulators |
02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
02/03/2005 | US20050027129 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
02/03/2005 | US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
02/03/2005 | US20050027007 Allylamides useful in the treatment of alzheimer's disease |
02/03/2005 | US20050026997 Baccatin III analog containing a small peptide moiety; can be conjugated to cell binding agents; improved potency |
02/03/2005 | US20050026988 Cyclopenta'b! indole derivatives as spla inhibitors |
02/03/2005 | US20050026985 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility |
02/03/2005 | US20050026976 Isoindolinone kinase inhibitors |
02/03/2005 | US20050026975 Such as ethyl 4-chloroacetamido-N-(3,4-dichlorobenzyl)indole-2-carboxylate use in the treatment of disease mediated by monocyte chemoattractant protein-1 |
02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
02/03/2005 | US20050026928 Chemical compounds |
02/03/2005 | US20050026916 Heterocyclic compounds as P2X7 ion channel blockers |
02/03/2005 | US20050026911 Benzotriazapinone salts and methods for using same |
02/03/2005 | US20050026903 Pyrazole compound; gastrointestinal disorders; central nervous system disorders |
02/03/2005 | US20050025996 Luminescence device, display apparatus and metal coordination compound |
02/03/2005 | US20050023507 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics |
02/03/2005 | CA2536383A1 Nicotinamide compounds useful as pde4 inhibitors |
02/03/2005 | CA2533626A1 Quinolinone derivatives as inhibitors of c-fms kinase |
02/03/2005 | CA2533624A1 Nicotinamide derivatives useful as pde4 inhibitors |
02/03/2005 | CA2532443A1 Tyrosine kinase inhibitors |
02/03/2005 | CA2532403A1 Ppar active compounds |
02/03/2005 | CA2532400A1 Tyrosine kinase inhibitors |
02/03/2005 | CA2532249A1 Nicotinamide derivatives useful as pde4 inhibitors |
02/03/2005 | CA2532071A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
02/03/2005 | CA2530352A1 Quinolone derivative or salt thereof |
02/02/2005 | EP1502916A1 Piperidine derivatives having ccr3 antagonism |
02/02/2005 | EP1501907A2 Solution-processable phosphorescent materials |
02/02/2005 | EP1501829A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
02/02/2005 | EP1501821A1 New organic compounds for electroluminescence and organic electroluminescent devices using the same |
02/02/2005 | EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators |
02/02/2005 | EP1501807A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
02/02/2005 | EP1501805A1 Substituted pyrazolyl compounds for the treatment of inflammation |
02/02/2005 | EP1501803A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
02/02/2005 | EP1501800A1 Bombesin antagonists |
02/02/2005 | EP1501798A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
02/02/2005 | EP1501797A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
02/02/2005 | EP1501796A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
02/02/2005 | EP1501795A1 Cinnamic acid amides |
02/02/2005 | EP1501786A1 Biphenyl carboxamides |
02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
02/02/2005 | EP1414814B1 6-aryl-4-aminopicolinates and their use as herbicides |
02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
02/02/2005 | EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
02/02/2005 | CN1575291A Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
02/02/2005 | CN1575290A Pyrimidine derivatives and pharmaceutical compositions containing that compounds |
02/02/2005 | CN1575284A Substituted triazole diamine derivatives as kinase inhibitors |
02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
02/02/2005 | CN1575279A Substituted thioacetamides |
02/02/2005 | CN1575165A Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |